PTCT

Ptc Therapeutics, Inc.

A biopharmaceutical company that develops treatments for rare diseases, with medicines including Sephience for PKU, Translarna and Emflaza for Duchenne muscular dystrophy, Evrysdi for spinal muscular atrophy, and the gene therapy Upstaza/Kebilidi. Founded in 1998 by RNA researcher Stuart Peltz, the company's name comes from "post-transcriptional control," the field of RNA biology it was built around.

Recent Activity

Show $

2026Q2

1 buy

Polen Capital ManagementNEW

+24.9K shares

Polen Capital ManagementNEW

+24.9K shares

2026Q1

1 sell

Bridgewater Associates LPEXIT

-16.2K shares

Bridgewater Associates LPEXIT

-16.2K shares

Loading more activity...